Navigation Links
Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
Date:4/15/2009

Institute of Technology, Medifocus has further refined the precision of the microwave focusing and control ability and developed a commercial system dedicated exclusively for the treatment of Breast Cancer. Please visit www.medifocusinc.com for more details.

Forward Looking Statements and Information

This News Release contains forward-looking statements which may not be based on historical fact. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The company disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments.


'/>"/>
SOURCE Medifocus Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CLEVELAND -- December 16, 2009 -- Every year ... are diagnosed, and 57,000 patients die of the disease, ... cancer among adults, after lung cancer. , As researchers ... colorectal cancer -- simultaneously generating thousands of studies producing ... professor and researcher of cancer and genetics at Case ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that Paul D. Mintz, ... new independent director, effective January 1, 2010. ,, ... transfusion medicine for more than 30 years. He is ... University of Virginia School of Medicine. He also serves ...
(Date:12/16/2009)... MDRX ) announced today that it will ... six months ended November 30, 2009 before the ... Allscripts management will host a conference call and ... information at 8:30 AM Eastern Standard Time that ... ,, Allscripts fiscal second quarter earnings will be ...
(Date:12/16/2009)... 16 The most widely used human embryonic stem ... social justice questions that must be addressed to ensure ... advances, according to a University of Michigan research team. ... the U-M team analyzed 47 embryonic stem cell lines, ... cell researchers. The scientists determined the genetic ancestry of ...
(Date:12/16/2009)... HealthSciences Institute will sponsor a ... teams and organizations who serve individuals at ... in employer, health plan, medical home and ... offer free, noncommercial webinars on topics, solutions ... management and care improvement. Each webinar will ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Immucor Appoints New Board Director 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3
... 9 A new report that features four,leading ... roundtable,discussion on key issues related to the privacy ... industry may best address those issues --,is now ... Experts Share Their Challenges",is the report,( http://www.ahima.org/emerging_issues/2008PrivacyRoundtable.pdf ) ...
... of tough breathing may help asthma sufferers breathe easier in ... Houston professor. , In a move that challenges ... first do no harm Richard Bond, associate professor ... taboo to treat asthma. Although counterintuitive, Bonds studies are ...
... of sexual,abuse and advocates for victim services rallied ... bring awareness to concerns of proposed state,funding levels., ... Support Our Services Rally was organized by the ... services remained level in Gov. Edward,Rendell,s proposed Fiscal ...
... rates kept 2006 episode under control , , WEDNESDAY, April 9 ... mumps in 20 years swept across eight Midwestern states, but ... , The scope of outbreak was limited, because the number ... against mumps is very high, explained study co-author Amy ...
... and protein it expresses may cause some cases of the ... small change in one gene, called CHI3L1, can increase a ... CHI3L1 causes the gene to release high levels of a ... have been associated with an increased risk of asthma in ...
... Mr. Muneo Takashi has been,named to head the ... Chicago). As the new Chief Executive Director, Takashi ... his assignment in Chicago., As Chief Executive ... its activities designed to facilitate business development,between Japan ...
Other Medicine News:Health News:Privacy Experts' Roundtable Report Will Highlight Privacy & Security Week 2Health News:First do no harm? UH prof taking opposite approach to treat asthma 2Health News:First do no harm? UH prof taking opposite approach to treat asthma 3Health News:First do no harm? UH prof taking opposite approach to treat asthma 4Health News:Pennsylvania Legislators Attend Victim Services Rally 2Health News:Mumps Outbreak in Midwest Could Have Been Worse 2Health News:Mumps Outbreak in Midwest Could Have Been Worse 3Health News:Researchers Find Gene Mutation That Increases Asthma Risk 2Health News:Researchers Find Gene Mutation That Increases Asthma Risk 3Health News:Muneo Takashi Named Chief Executive Director of Japan's Midwest Trade Office 2
(Date:12/16/2009)... CVS/pharmacy and MinuteClinic health care centers ... H1N1 vaccine in 20 states and Washington, D.C. ... receiving H1N1 vaccines continue, many states have lifted ... receive the shot while supplies last. In ... is available at MinuteClinic locations across the country ...
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... Dec. 16 Naurex Inc., a new ... and other CNS disorders based on its novel ... has initiated a Phase I clinical trial of ... the first subjects in the study. GLYX-13, ... modulator of the NMDA receptor, is initially being ...
Breaking Medicine Technology:CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 1DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 2DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 3PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 1PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 2PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 3New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 1New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 2New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 3
... May 30 (ASX: PGL;,Nasdaq: PGLA) New ... will,be presented tomorrow at the American Association ... by Progen,s collaborators at the Johns,Hopkins University., ... that compounds in Progen,s,existing preclinical cancer epigenetics ...
... Epeius Biotechnologies,( http://www.epeiusbiotech.com ) announced today the results ... metastatic bone and soft tissue sarcoma (J,Clin Oncol ... so far only targeted,gene therapy vector that has ... this open label study, cohorts of 6 to ...
Other Medicine Technology:Presentation of Data on Progen's Cancer Epigenetic Targets Platform 2Presentation of Data on Progen's Cancer Epigenetic Targets Platform 3Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008) 2
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Long Reach Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Binding, Graduated, Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
Medicine Products: